Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior
Open Access
- 19 May 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuroinflammation
- Vol. 8 (1), 54
- https://doi.org/10.1186/1742-2094-8-54
Abstract
Interleukin (IL)-6 is produced in the brain during peripheral infection and plays an important but poorly understood role in sickness behavior. Therefore, this study investigated the capacity of soluble gp130 (sgp130), a natural inhibitor of the IL-6 trans-signaling pathway to regulate IL-6 production in microglia and neurons in vitro and its effects on lipopolysaccharide (LPS)-induced sickness behavior in vivo. A murine microglia (BV.2) and neuronal cell line (Neuro.2A) were used to study the effects of stimulating and inhibiting the IL-6 signaling pathway in vitro. In vivo, adult (3-6 mo) BALB/c mice received an intracerebroventricular (ICV) injection of sgp130 followed by an intraperitoneal (i.p.) injection of LPS, and sickness behavior and markers of neuroinflammation were measured. Soluble gp130 attenuated IL-6- and LPS-stimulated IL-6 receptor (IL-6R) activation along with IL-6 protein release in both microglial (BV.2) and neuronal (Neuro.2A) cell types in vitro. Moreover, in vivo experiments showed that sgp130 facilitated recovery from LPS-induced sickness, and this sgp130-associated recovery was paralleled by reduced IL-6 receptor signaling, mRNA, and protein levels of IL-6 in the hippocampus. Taken together, the results show that sgp130 may exert an anti-inflammatory effect on microglia and neurons by inhibiting IL-6 binding. These data indicate that sgp130 inhibits the LPS-induced IL-6 trans-signal and show IL-6 and its receptor are involved in maintaining sickness behavior.Keywords
This publication has 54 references indexed in Scilit:
- Cannabinoid 1 Receptor and Interleukin-6 Receptor Together Induce Integration of Protein Kinase and Transcription Factor Signaling to Trigger Neurite OutgrowthPublished by Elsevier BV ,2010
- Consuming a Diet Supplemented with Resveratrol Reduced Infection-Related Neuroinflammation and Deficits in Working Memory in Aged MiceRejuvenation Research, 2009
- Central inhibition of interleukin-1β ameliorates sickness behavior in aged miceBrain, Behavior, and Immunity, 2009
- Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharideNeurobiology of Aging, 2008
- Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or StressNeuroimmunomodulation, 2008
- Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Immune-To-Brain Signaling: How Important are the Blood–Brain Barrier-independent Pathways?Molecular Neurobiology, 2008
- Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1Proceedings of the National Academy of Sciences of the United States of America, 2008
- Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120Neurobiology of Aging, 2008
- Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune systemBrain, Behavior, and Immunity, 2008